The Japan axillary hyperhidrosis treatment market is experiencing significant growth, with projections indicating a rise from USD 66.9 million in 2025 to USD 134.1 million by 2035, reflecting a CAGR ...

The India axillary hyperhidrosis treatment market is on a strong growth trajectory, projected to expand at a CAGR of 10.1%, rising from USD 75.2 million in 2025 to USD 196.8 million by 2035. This ...

Primary axillary hyperhidrosis is a condition characterized by excessive underarm sweating and has long presented challenges ...

This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum ...